UnitedHealth Group Incorporated (NYSE:UNH) is Bell Asset Management Ltd's 7th Largest Position

Bell Asset Management Ltd lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 3.3% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 28,496 shares of the healthcare conglomerate's stock after buying an additional 922 shares during the quarter. UnitedHealth Group makes up about 2.6% of Bell Asset Management Ltd's holdings, making the stock its 7th largest position. Bell Asset Management Ltd's holdings in UnitedHealth Group were worth $14,415,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in the business. NewSquare Capital LLC purchased a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $25,000. Hurley Capital LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter worth $28,000. AlphaMark Advisors LLC acquired a new stake in shares of UnitedHealth Group during the fourth quarter valued at $30,000. Aster Capital Management DIFC Ltd acquired a new position in UnitedHealth Group in the 4th quarter valued at about $30,000. Finally, Promus Capital LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth about $32,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm's stock in a transaction on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 0.33% of the company's stock.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $524.94 on Monday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The firm's fifty day moving average price is $509.24 and its 200 day moving average price is $541.85. The company has a market capitalization of $480.17 billion, a price-to-earnings ratio of 33.87, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73.

Remove Ads

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group's quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter last year, the firm earned $5.83 EPS. On average, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.60%. UnitedHealth Group's dividend payout ratio (DPR) is presently 54.19%.

Wall Street Analysts Forecast Growth

UNH has been the topic of several recent analyst reports. Wells Fargo & Company reduced their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating on the stock in a research note on Tuesday, January 28th. Cantor Fitzgerald restated an "overweight" rating and set a $700.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. HSBC upgraded UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 target price on the stock in a research report on Friday, January 10th. StockNews.com raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Thursday, January 23rd. Finally, Piper Sandler lowered their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a report on Thursday, January 2nd. Twenty research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus target price of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.